NS-041

N/A

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameNS-041
Drug Alias NameNS-041
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv7.2 stimulantsPotassium voltage-gated channel subfamily KQT member 3 stimulants
TargetsVoltage-gated potassium channel subunit Kv7.2Potassium voltage-gated channel subfamily KQT member 3
Therapy Area/IndicationsDepressive Disorder, MajorDepressive DisorderSeizures +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNuoshen Pharmaceutical (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNuoshen Pharmaceutical (Shanghai) Co LtdLivzon(Group) Pharmaceutical Factory
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorDepressive DisorderSeizures +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A